Importance Tranexamic acid (TXA) is an efficient antifibrinolytic agent; however, concerns
remain about the potential adverse effects, particularly vascular occlusive events, that may …

Antecedentes La hemorragia posparto (HPP) es una complicación frecuente y
potencialmente mortal del trabajo de parto. Se dispone de varias opciones para prevenir la …

Objective This study aimed to assess the efficacy and safety of prophylactic tranexamic acid
administration vs standard uterotonic agents alone among women undergoing cesarean …

Background A number of clinical systematic review and meta-analysis have been published
on the use of tranexamic in the obstetric setting. The aim of this meta-analysis was to …

Background: To assess the efficacy and safety of tranexamic acid (TA) in reducing blood
loss and lowering transfusion needs for patients undergoing caesarean section (CS) or …

Background An antifibrinolytic agent that blocks lysine-binding sites on plasminogen
molecules, tranexamic acid reduces bleeding-related mortality in women with postpartum …

Background Postpartum hemorrhage (PPH) is one of the important risk factors leading to
maternal mortality and intervention is essential. Oxytocin therapy is widely used clinically …

OBJECTIVE Tranexamic acid is a cost-effective intervention for the prevention of postpartum
hemorrhage among women who undergo cesarean delivery, but the evidence to support its …

Background Objective to assess the value of preoperative tranexamic acid (TXA) in
reduction of intraoperative and postoperative blood loss in high-risk cesarean delivery (CD) …

Aim To analyse the effectiveness of Tranexamic Acid (TXA) in reducing blood loss during
elective caesarean section. Materials and Methods This interventional, randomized, parallel …